Funding Opportunity RFA-CA-17-047 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.

Funding Opportunity RFA-CA-17-048 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.

Funding Opportunity RFA-CA-17-045 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.

Funding Opportunity PAR-17-306 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity; and 2) that could be made scalable and sustainable for broad use across the nation. This FOA provides support for up to 5 years for research planning, intervention delivery, and follow-up activities.

Funding Opportunity PAR-18-307 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fund highly innovative and promising research aimed at developing multi-level physical activity intervention programs acting on at least two levels of the socioecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity; and 2) that could be made scalable and sustainable for broad use across the nation. This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by a possible transition to expanded research support (R33 phase) for optimizing the intervention and conducting larger-scale feasibility studies. Transition to the R33 depends on the completion of applicant-defined milestones, as well as program priorities and the availability of funds.

Funding Opportunity PAR-17-305 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcoholism and Alcohol Abuse (NIAAA), National Institutes of Health, is a limited competition FOA encouraging a resource project (R28) application from a center currently supported under an existing grant, entitled Brain Tissue Resource Center for Alcohol Research to (i) develop a bank of brain tissues (fresh-frozen and formalin-fixed) from alcoholic and control cases with confirmed clinical and pathological diagnoses, (ii) develop and promote a prospective brain donor program in Australia (Using our Brains) to enhance the brain bank, (iii) establish an associated DNA (blood) bank from the brain donor group, and (iv) invite research groups with an interest in alcohol-related brain damage to submit applications for studies using these tissues.

Notice NOT-CA-17-096 from the NIH Guide for Grants and Contracts

Notice NOT-CA-17-097 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Commercial Programme Delivery Lead - Genomics/Bioinformatics Central London - 100,000 Genomes Project - Fixed-term (2 years)! Paramount are working in partnership with Genomics England to expand their team in order to deliver success with the 100,000 London, England

Negotiable: Paramount Recruitment: Software Developer - Bioinformatics London Paramount are working in partnership with Genomics England to expand their team in order to deliver success Paramount are working in partnership with Genomics England to expand their team in order to with the 10 London, England

Knowledge of general developmental biology and bioinformatics principles is desirable. Successful candidates will display high levels of intellectual curiosity...
From Cellular Dynamics - Tue, 10 Oct 2017 03:08:21 GMT - View all Madison, WI jobs

Develop and optimize signal processing, bioinformatics, and data analysis code and algorithms for speed and memory usage in a production environment dealing...
From GenapSys - Mon, 09 Oct 2017 21:24:07 GMT - View all United States jobs

GBP43000 - GBP49000 per annum + excellent benefits: Wellcome Trust Sanger Institute: Salary range £43,000 to £49,000 pa plus excellent benefits. A highly motivated Senior Staff Scientist is needed to work within a world leading Malaria genomics team that uses cutting edge technology to study the comparative and functional genomics of mala Cambridgeshire, England

Negotiable: Paramount Recruitment: Commercial Partnerships Manager - Genomics/Bioinformatics Central London - 100,000 Genomes Project - Commercial Division! Paramount are working in partnership with Genomics England to expand their team in order to deliver success with the 100,000 Geno London, England

Negotiable: Paramount Recruitment: Cancer Analyst - Bioinformatics 100,000 Genomes Project, competitive salary, WGS, NGS Paramount are working in partnership with Genomics England to expand their team in order to deliver success with the 100,000 Genomes Project. London, England

From its start in 1947, UMUC has demonstrated its commitment to adult learners. The Bioinformatics program at UMUC....
From University of Maryland University College - Sat, 07 Oct 2017 08:01:16 GMT - View all Remote jobs

Driven by the passion for elevating the science and utility of genetic testing, Natera is committed to helping families identify and manage genetic diseases....
From Natera - Fri, 06 Oct 2017 23:44:04 GMT - View all Remote jobs

The science and mathematics departments are housed in a recent $44M science building. Names and contact information for a minimum of three (3) professional...
From University of Wisconsin System - Fri, 06 Oct 2017 22:34:44 GMT - View all Menomonie, WI jobs

Previous experience in analysis of fungal-plant interactions, plant molecular biology, plant molecular genetics and bioinformatics is preferred....
From Oak Ridge Associated Universities - Fri, 06 Oct 2017 21:56:19 GMT - View all Idaho jobs

Funding Opportunity RFA-DK-17-033 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to seek applications for the Developmental Centers for Interdisciplinary Research in Benign Urology Program (P20). Among the goals of this Program is to further advance research in benign urology by building research teams and facilitating resources generation and sharing. The research teams should be composed of individuals with complementary expertise who propose to either develop innovative resources (Resource Development Projects) or a new research project (Scientific Research Projects) that utilize integrative approaches to address questions relevant to benign urological diseases or disorders. Patient-centered research is encouraged. Resources developed by the Resource Development Projects will be shared upon validation while resources developed within the Scientific Research Projects will be shared at the end or termination of the award, as appropriate and consistent with the program goal of further advancing research. Each Developmental Center is centered on a single Project and must contain an Administrative Core and an Educational Enrichment Program. As part of the efforts of the Division of Kidney, Urologic and Hematologic Diseases (DKUH) to expand and enhance benign urology research, the Developmental Centers Program will work in partnership with the George M. O'Brien Urology Cooperative Research Centers Program (U54) and the Multidisciplinary K12 Urologic Research (KURe) Career Development Program.